VELAGA VENKATA SATHYA SAI APPALARAJU

Dr. VELAGA VENKATA SATHYA SAI APPALARAJU


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
NRNur Syafiqah Rahim
Nur Syafiqah Rahim
YWYuan Seng Wu
Yuan Seng Wu
MSMaw Shin Sim
Maw Shin Sim
VAVELAGA VENKATA SATHYA SAI APPALARAJU
VELAGA VENKATA SATHYA SAI APPALARAJU
Srinivasa Reddy BonamSrinivasa Reddy Bonam
Srinivasa Reddy Bonam
RGrhanye guad
rhanye guad
There are six members of the transmembrane 4 superfamily (TM4SF) that have similar topology and sequence homology. Physiologically, they regulate tissue differentiation, signal transduction pathways, cellular activation, proliferation, motility, adhesion, and angiogenesis. Accumulating evidence has demonstrated, among six TM4SF members, the regulatory roles of transmembrane 4 L6 domain family members, particularly TM4SF1, TM4SF4, and TM4SF5, in cancer angiogenesis, progression, and chemoresistance. Hence, targeting derailed TM4SF for cancer therapy has become an emerging research area. As compared to others, this review aimed to present a focused insight and update on the biological roles of TM4SF1, TM4SF4, and TM4SF5 in the progression, metastasis, and chemoresistance of various cancers. Additionally, the mechanistic pathways, diagnostic and prognostic values, and the potential and efficacy of current anti-TM4SF antibody treatment were also deciphered. It also recommended the exploration of other interactive molecules to be implicated in cancer progression and chemoresistance, as well as potential therapeutic agents targeting TM4SF as future perspectives. Generally, these three TM4SF members interact with different integrins and receptors to significantly induce intracellular signaling and regulate the proliferation, migration, and invasion of cancer cells. Intriguingly, gene silencing or anti-TM4SF antibody could reverse their regulatory roles deciphered in different preclinical models. They also have prognostic and diagnostic value as their high expression was detected in clinical tissues and cells of various cancers. Hence, TM4SF1, TM4SF4, and TM4SF5 are promising therapeutic targets for different cancer types preclinically and deserve further investigation.

14 December 2025 in Iranian Journal of Pharmaceutical Research
Verified
Journal Article
Open access
SASHERYAR AFZAL
SHERYAR AFZAL
VAVELAGA VENKATA SATHYA SAI APPALARAJU
VELAGA VENKATA SATHYA SAI APPALARAJU
AAAli Attiq
Ali Attiq
IMIram Malik
Iram Malik
IAIbrahim Albokhadaim
Ibrahim Albokhadaim
GAGhazi Aljabl
Ghazi Aljabl
Background: Leuenbergeria bleo, a medicinal plant with traditional therapeutic uses, has attracted interest for its antidiabetic potential. Objectives: This study evaluated the antihyperglycemic effects of its leaf extracts in an alloxan-induced diabetic rat model. Methods: The leaves of L. bleo were sequentially extracted using petroleum ether, chloroform, and methanol. Phytochemical screening was conducted to identify bioactive compounds such as phytosterols, alkaloids, tannins, and flavonoids. Thirty healthy Albino Wistar rats were divided into five groups. Diabetes was induced in four groups via intraperitoneal injection of alloxan monohydrate (140 mg/kg). The diabetic rats were treated with either chloroform or methanol extracts of L. bleo (500 mg/kg/day) for five days, with metformin (100 mg/kg/day) serving as the standard reference treatment. Blood glucose levels were monitored daily, and body weight was recorded on days 1, 3, and 5. Results: Methanol extract significantly reduced blood glucose levels by 12.23% by day 5, compared to a 6.35% reduction with chloroform extract. Additionally, the methanol extracts mitigated weight loss, resulting in an 8.07% increase in body weight, while the diabetic control group experienced a 26.72% decrease. The effects of the methanol extract were comparable to metformin, though slightly less potent. Leuenbergeria bleo exhibits modest antihyperglycemic potential, particularly in its methanol extract, which also stabilizes body weight in diabetic rats. Conclusions: The presence of flavonoids and alkaloids likely contributes to these effects. Further research is warranted to elucidate the exact mechanisms and explore L. bleo’s potential as a natural alternative therapy for diabetes management.

22 April 2026 in Cytotechnology
Verified
Journal Article
Closed access
PDF file
ASAnnatasha Stephen
Annatasha Stephen
YWYuan Seng Wu
Yuan Seng Wu
NRNur Syafiqah Rahim
Nur Syafiqah Rahim
BTBernadette Xin Jie Tune
Bernadette Xin Jie Tune
MLMICHELLE FELICIA LEE
MICHELLE FELICIA LEE
VAVELAGA VENKATA SATHYA SAI APPALARAJU
VELAGA VENKATA SATHYA SAI APPALARAJU